The Gap-junction inhibitor Carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells

Journal of Neuroimmunology

Volumn 240-241, Issue , 2011, Pages 58-64

  Endong, Li ^a   Shijie, Jin ^a   Sonobe, Yoshifumi ^a   Di, Ma ^a   Hua, Li ^a   Kawanokuchi, Jun ^a   Mizuno, Tetsuya ^a   Suzumura, Akio ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Carbenoxolone; Experimental autoimmune encephalomyelitis; IL 17; IL 23 p19; Protein phosphatase 2A

Indexed keywords

CARBENOXOLONE; INTERLEUKIN 23P19; PHOSPHOPROTEIN PHOSPHATASE 2A;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; DRUG MECHANISM; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TH17 CELL;

ANIMALS; ANTI-ULCER AGENTS; ANTIGEN-PRESENTING CELLS; CARBENOXOLONE; CELL DIFFERENTIATION; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GAP JUNCTIONS; INTERLEUKIN-23; MICE; MICE, INBRED C57BL; TH17 CELLS; UP-REGULATION;

EID: 83555176359     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.09.012     Document Type: Article

References (38)

1. + T(H)-17 cells in relapsing EAE. Nat. Immunol. 2007, 8:172-180.
2. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
3. Chang J., Voorhees T.J., Liu Y., Zhao Y., Chang C.H. Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2A. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8340-8345.
4. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 1989, 58:453-508.
5. de Groot J.R., Veenstra T., Verkerk A.O., Wilders R., Smits J.P., Wilms-Schopman F.J., Wiegerinck R.F., Bourier J., Belterman C.N., Coronel R., Verheijck E.E. Conduction slowing by the gap junctional uncoupler carbenoxolone. Cardiovasc. Res. 2003, 60:288-297.
6. Doi Y., Mizuno T., Maki Y., Jin S., Mizoguchi H., Ikeyama M., Doi M., Michikawa M., Takeuchi H., Suzumura A. Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid beta neurotoxicity in in vitro and in vivo models of Alzheimer's disease. Am. J. Pathol. 2009, 175:2121-2132.
7. Dutta R., Trapp B.D. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007, 68:S22-31. discussion S43-54.
8. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., Noelle R.J., Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005, 11:328-334.
9. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
10. Hemmer B., Archelos J.J., Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 2002, 3:291-301.
11. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
12. Kato H., Ito A., Kawanokuchi J., Jin S., Mizuno T., Ojika K., Ueda R., Suzumura A. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. Mult. Scler. 2004, 10:651-659.
13. Kray A.E., Carter R.S., Pennington K.N., Gomez R.J., Sanders L.E., Llanes J.M., Khan W.N., Ballard D.W., Wadzinski B.E. Positive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2A. J. Biol. Chem. 2005, 280:35974-35982.
14. Laird D.W. The gap junction proteome and its relationship to disease. Trends Cell Biol. 2010, 20:92-101.
15. Li H., Sonobe Y., Tabata H., Liang J., Jin S., Doi Y., Kawanokuchi J., Takeuchi H., Mizuno T., Suzumura A. Tumor necrosis factor-α promotes granulocyte-macrophage colony-stimulating factor-stimulated microglia to differentiate into competent dendritic cell-like antigen-presenting cells. Clin. Exp. Neuroimmunol. 2011, 2:1-11.
16. Li J., Gran B., Zhang G.X., Ventura E.S., Siglienti I., Rostami A., Kamoun M. Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J. Neurol. Sci. 2003, 215:95-103.
17. Li S., Wang L., Berman M.A., Zhang Y., Dorf M.E. RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol. Cell 2006, 24:497-509.
18. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
19. McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005, 11:335-339.
20. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
21. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
22. Pitt D., Werner P., Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 2000, 6:67-70.
23. Prineas J.W., McDonald W.I., Franklin R.J.M. Demyelinating diseases. Greenfield's Neuropathology 2002, 471-550. Arnold, London. D.I. Graham, P.L. Lantos (Eds.).
24. Qian X., Ning H., Zhang J., Hoft D.F., Stumpo D.J., Blackshear P.J., Liu J. Posttranscriptional regulation of IL-23 expression by IFN-{gamma} through tristetraprolin. J. Immunol. 2011, 186:6454-6464.
25. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Capello E., Mancardi G.L., Aloisi F. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 2006, 65:124-141.
26. Jin S., Takeuchi H., Yawata I., Harada Y., Sonobe Y., Doi Y., Liang J., Li H., Yasuoka S., Zhou Y., Noda M., Kawanokuchi J., Mizuno T., Suzumura A. Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice. Tohoku J. Exp. Med. 2009, 217:87-92.
27. Sonobe Y., Jin S., Wang J., Kawanokuchi J., Takeuchi H., Mizuno T., Suzumura A. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J. Exp. Med. 2007, 213:329-339.
28. Sonobe Y., Yawata I., Kawanokuchi J., Takeuchi H., Mizuno T., Suzumura A. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 2005, 1040:202-207.
29. Sun L., Stoecklin G., Van Way S., Hinkovska-Galcheva V., Guo R.F., Anderson P., Shanley T.P. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J. Biol. Chem. 2007, 282:3766-3777.
30. Suzumura A., Mezitis S.G., Gonatas N.K., Silberberg D.H. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. J. Neuroimmunol. 1987, 15:263-278.
31. Takeuchi H., Jin S., Suzuki H., Doi Y., Liang J., Kawanokuchi J., Mizuno T., Sawada M., Suzumura A. Blockade of microglial glutamate release protects against ischemic brain injury. Exp. Neurol. 2008, 214:144-146.
32. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 2006, 281:21362-21368.
33. Takeuchi H., Mizoguchi H., Doi Y., Jin S., Noda M., Liang J., Li H., Zhou Y., Mori R., Yasuoka S., Li E., Parajuli B., Kawanokuchi J., Sonobe Y., Sato J., Yamanaka K., Sobue G., Mizuno T., Suzumura A. Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. PLoS One 2011, 6:e21108.
34. Takeuchi H., Mizuno T., Zhang G., Wang J., Kawanokuchi J., Kuno R., Suzumura A. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 2005, 280:10444-10454.
35. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., Bö L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285.
36. Wang J., Takeuchi H., Sonobe Y., Jin S., Mizuno T., Miyakawa S., Fujiwara M., Nakamura Y., Kato T., Muramatsu H., Muramatsu T., Suzumura A. Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3915-3920.
37. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
38. Yawata I., Takeuchi H., Doi Y., Liang J., Mizuno T., Suzumura A. Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors. Life Sci. 2008, 82:1111-1116.